BSN Capital Partners’s Procter & Gamble PG Stock Holding History

BSN Capital Partners’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-50,000	Closed	-$8.33M	–	39
2024 Q3	$8.33M	Buy	+50,000	New	+$8.49M	1.62%	28
2021 Q1	–	Sell	-132,666	Closed	-$18.5M	–	10
2020 Q4	$18.5M	Buy	+132,666	New	+$18.5M	4.64%	8

Other funds holding PG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BSN Capital Partners's PG Position: Q4 2024 in Review

BSN Capital Partners sold out of Procter & Gamble (PG) in Q4 2024, closing a stake of 50,000 shares — an estimated $8.33M sold.

BSN Capital Partners first reported a position in PG in Q4 2020 and held it in 2 quarters. The position peaked at $18.5M in Q4 2020. 4,003 funds tracked by Wall St. Rank hold PG as of Q4 2024.

BSN Capital Partners reported no remaining Procter & Gamble position as of Q4 2024 after selling out during the quarter.
BSN Capital Partners sold 50,000 Procter & Gamble shares in Q4 2024, an estimated $8.33M.
BSN Capital Partners first reported a position in Procter & Gamble in Q4 2020 and held it in 2 quarters.
BSN Capital Partners's Procter & Gamble position peaked at $18.5M in Q4 2020.
4,003 funds tracked by Wall St. Rank held Procter & Gamble as of Q4 2024.

Based on BSN Capital Partners's 13F filing for Q4 2024, filed 28 Jan 2025.